Pages that link to "Q28239595"
Jump to navigation
Jump to search
The following pages link to Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (Q28239595):
Displaying 50 items.
- Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? (Q22251049) (← links)
- Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex (Q24296678) (← links)
- Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases (Q24315937) (← links)
- Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18 (Q24319697) (← links)
- A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition (Q24321639) (← links)
- hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells (Q24529984) (← links)
- Epigenetic differences arise during the lifetime of monozygotic twins (Q24531005) (← links)
- A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16 (Q24534923) (← links)
- MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells (Q24570117) (← links)
- Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? (Q24603107) (← links)
- Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers (Q24605342) (← links)
- A decade of exploring the cancer epigenome - biological and translational implications (Q24614467) (← links)
- The histone deacetylase SIRT2 stabilizes Myc oncoproteins (Q24622277) (← links)
- Epigenetic alterations in aging (Q24625376) (← links)
- Dietary histone deacetylase inhibitors: from cells to mice to man (Q24641899) (← links)
- Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells (Q24642670) (← links)
- CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2 (Q24684224) (← links)
- Epigenetics of cervical cancer. An overview and therapeutic perspectives (Q24812104) (← links)
- One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling (Q26740548) (← links)
- Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy (Q26746038) (← links)
- The world of protein acetylation (Q26746231) (← links)
- The Impact of External Factors on the Epigenome: In Utero and over Lifetime (Q26746703) (← links)
- The Metabolic Impact on Histone Acetylation and Transcription in Ageing (Q26747254) (← links)
- DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics (Q26749421) (← links)
- Orchestrating epigenetic roles targeting ocular tumors (Q26751251) (← links)
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia (Q26767024) (← links)
- The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis (Q26771181) (← links)
- Epigenetic regulation in cardiac fibrosis (Q26774536) (← links)
- Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? (Q26775413) (← links)
- Panobinostat for the treatment of multiple myeloma: the evidence to date (Q26778674) (← links)
- Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia (Q26781526) (← links)
- Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations (Q26781745) (← links)
- The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications (Q26783814) (← links)
- Epigenomics of cancer - emerging new concepts (Q26830534) (← links)
- A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics (Q26852571) (← links)
- HDAC inhibitors and immunotherapy; a double edged sword? (Q26853102) (← links)
- Mechanisms of epigenetic regulation of leukemia onset and progression (Q26861785) (← links)
- Common features of chromatin in aging and cancer: cause or coincidence? (Q26864051) (← links)
- Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention (Q26994739) (← links)
- Histone deacetylases as targets for treatment of multiple diseases (Q27000389) (← links)
- Proteomics in epigenetics: new perspectives for cancer research (Q27014943) (← links)
- Epigenetics meets radiation biology as a new approach in cancer treatment (Q27014984) (← links)
- Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation (Q27021965) (← links)
- New and emerging HDAC inhibitors for cancer treatment (Q27022413) (← links)
- Cancer control and prevention by nutrition and epigenetic approaches (Q27024282) (← links)
- Sirtuin-dependent epigenetic regulation in the maintenance of genome integrity (Q27026871) (← links)
- Keeping chromatin quiet: how nucleosome remodeling restores heterochromatin after replication (Q27027704) (← links)
- Altered histone modifications in gliomas (Q27027924) (← links)
- Microbiota impact on the epigenetic regulation of colorectal cancer (Q27028132) (← links)
- Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice (Q27349142) (← links)